Oligonucleotide Synthesis Market by Offering (Synthesized Oligonucleotides [Products {Primers, Probes, Large-Scale Synthesis Oligonucleotides, Intermediate-Scale Synthesis Oligonucleotides, Linkers & Adaptors}, Services {Custom Oligonucleotides, Pre-Designed Oligonucleotides}], Reagents & Consumables, Equipment), by Application (Research [PCR, qPCR, Sequencing, Gene Synthesis], Diagnostics, Therapeutics [RNAi, Nucleic Acid Aptamers, DNA/Antisense, Immunotherapy Applications]), by End User (Academic Research Institutes, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies), by Geography (U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, Brazil, South Africa) - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Offering

1.3.2 Market Segmentation by Application

1.3.3 Market Segmentation by End User

1.3.4 Market Segmentation by Geography

1.3.5 Analysis Period

1.3.6 Market Data Reporting Unit

1.3.6.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Offering

4.1.1.1 Synthesized oligonucleotides

4.1.1.1.1 By products

4.1.1.1.1.1 Primers

4.1.1.1.1.2 Probes

4.1.1.1.1.3 Large-scale synthesis oligonucleotides

4.1.1.1.1.4 Intermediate-scale synthesis oligonucleotides

4.1.1.1.1.5 Linkers and adaptors

4.1.1.1.2 By services

4.1.1.1.2.1 Custom oligonucleotides

4.1.1.1.2.2 Pre-designed oligonucleotides

4.1.1.2 Reagents and consumables

4.1.1.3 Equipment

4.1.2 By Application

4.1.2.1 Research

4.1.2.1.1 Polymerase chain reaction (PCR)

4.1.2.1.2 Quantitative polymerase chain reaction (qPCR)

4.1.2.1.3 Sequencing

4.1.2.1.4 Gene synthesis

4.1.2.1.5 Others

4.1.2.2 Diagnostics

4.1.2.3 Therapeutics

4.1.2.3.1 RNAi

4.1.2.3.2 Nucleic acid aptamers

4.1.2.3.3 DNA/antisense oligonucleotides

4.1.2.3.4 Immunotherapy applications

4.1.3 By End User

4.1.3.1 Academic research institutes

4.1.3.2 Diagnostic laboratories

4.1.3.3 Pharmaceutical and biotechnology companies

4.1.3.4 Others

4.2 Market Dynamics

4.2.1 Drivers

4.2.1.1 Technological advancements in oligonucleotide synthesis products

4.2.1.2 Increasing support from government organizations

4.2.1.3 Increasing research activities in synthetic biology

4.2.1.4 Increasing burden of cancer and infectious diseases

4.2.1.5 Impact analysis of drivers on market forecast

4.2.2 Restraints

4.2.2.1 Stringent regulatory requirements

4.2.2.2 Lack of techniques for large-scale synthesis of oligonucleotide

4.2.2.3 Impact analysis of restraints on market forecast

4.2.3 Opportunities

4.2.3.1 Growing focus on personalized medicine

4.3 Porter’s Five Forces Analysis

4.3.1 Bargaining Power of Buyers

4.3.2 Bargaining Power of Suppliers

4.3.3 Intensity of Rivalry

4.3.4 Threat of New Entrants

4.3.5 Threat of Substitutes

Chapter 5. Global Market Size and Forecast

5.1 By Product

5.1.1 Synthesized Oligonucleotides Market by Type

5.1.1.1 Synthesized oligonucleotides products market by type

5.1.1.2 Synthesized oligonucleotides services market by type

5.2 By Application

5.2.1 Oligonucleotide Synthesis Market for Research by Type

5.2.2 Oligonucleotide Synthesis Market for Therapeutics by Type

5.3 By End User

5.4 By Region

Chapter 6. North America Market Size and Forecast

6.1 By Product

6.1.1 Synthesized Oligonucleotides Market by Type

6.1.1.1 Synthesized oligonucleotides products market by type

6.1.1.2 Synthesized oligonucleotides services market by type

6.2 By Application

6.2.1 Oligonucleotide Synthesis Market for Research by Type

6.2.2 Oligonucleotide Synthesis Market for Therapeutics by Type

6.3 By End User

6.4 By Country

Chapter 7. Europe Market Size and Forecast

7.1 By Product

7.1.1 Synthesized Oligonucleotides Market by Type

7.1.1.1 Synthesized oligonucleotides products market by type

7.1.1.2 Synthesized oligonucleotides services market by type

7.2 By Application

7.2.1 Oligonucleotide Synthesis Market for Research by Type

7.2.2 Oligonucleotide Synthesis Market for Therapeutics by Type

7.3 By End User

7.4 By Country

Chapter 8. APAC Market Size and Forecast

8.1 By Offering

8.1.1 Synthesized Oligonucleotides Market by Type

8.1.1.1 Synthesized oligonucleotides products market by type

8.1.1.2 Synthesized oligonucleotides services market by type

8.2 By Application

8.2.1 Oligonucleotide Synthesis Market for Research by Type

8.2.2 Oligonucleotide Synthesis Market for Therapeutics by Type

8.3 By End User

8.4 By Country

Chapter 9. LATAM Market Size and Forecast

9.1 By Offering

9.1.1 Synthesized Oligonucleotides Market by Type

9.1.1.1 Synthesized oligonucleotides products market by type

9.1.1.2 Synthesized oligonucleotides services market by type

9.2 By Application

9.2.1 Oligonucleotide Synthesis Market for Research by Type

9.2.2 Oligonucleotide Synthesis Market for Therapeutics by Type

9.3 By End User

9.4 By Country

Chapter 10. MEA Market Size and Forecast

10.1 By Offering

10.1.1 Synthesized Oligonucleotides Market by Type

10.1.1.1 Synthesized oligonucleotides products market by type

10.1.1.2 Synthesized oligonucleotides services market by type

10.2 By Application

10.2.1 Oligonucleotide Synthesis Market for Research by Type

10.2.2 Oligonucleotide Synthesis Market for Therapeutics by Type

10.3 By End User

10.4 By Country

Chapter 11. Competitive Landscape

11.1 Product Benchmarking of Key Players

11.2 Global Strategic Developments of Key Players

11.2.1 Mergers and Acquisitions

11.2.2 Product Launches

11.2.3 Partnerships

11.2.4 Other Developments

Chapter 12. Company Profiles

12.1 Eurofins Scientific SE

12.1.1 Business Overview

12.1.2 Product and Service Offerings

12.1.3 Key Financial Summary

12.2 LGC Limited

12.2.1 Business Overview

12.2.2 Product and Service Offerings

12.2.3 Key Financial Summary

12.3 Danaher Corporation

12.3.1 Business Overview

12.3.2 Product and Service Offerings

12.3.3 Key Financial Summary

12.4 GeneDesign Inc.

12.4.1 Business Overview

12.4.2 Product and Service Offerings

12.5 Maravai LifeSciences Inc.

12.5.1 Business Overview

12.5.2 Product and Service Offerings

12.6 Kaneka Eurogentec S.A.

12.6.1 Business Overview

12.6.2 Product and Service Offerings

12.7 General Electric Company

12.7.1 Business Overview

12.7.2 Product and Service Offerings

12.7.3 Key Financial Summary

12.8 Thermo Fisher Scientific Inc.

12.8.1 Business Overview

12.8.2 Product and Service Offerings

12.8.3 Key Financial Summary

12.9 Merck KGaA

12.9.1 Business Overview

12.9.2 Product and Service Offerings

12.9.3 Key Financial Summary

12.10 Genscript Biotech Corporation

12.10.1 Business Overview

12.10.2 Product and Service Offerings

12.10.3 Key Financial Summary

12.11 Nitto Denko Avecia Inc.

12.11.1 Business Overview

12.11.2 Product and Service Offerings

Chapter 13. Appendix

13.1 Abbreviations

13.2 Sources and References

13.3 Related Reports

 

List of Tables

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 NUMBER OF MORTALITIES DUE TO VARIOUS DISEASES, GLOBALLY

TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 NIH GUIDELINES IN THE U.S., BY EXPERIMENT TYPE

TABLE 5 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 6 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY OFFERING, $M (2019–2024)

TABLE 7 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY OFFERING, $M (2025–2030)

TABLE 8 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2019–2024)

TABLE 9 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2025–2030)

TABLE 10 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES PRODUCTS MARKET, BY TYPE $M (2019–2024)

TABLE 11 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES PRODUCTS MARKET, BY TYPE, $M (2025–2030)

TABLE 12 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES SERVICES MARKET, BY TYPE, $M (2019–2024)

TABLE 13 GLOBAL SYNTHESIZED OLIGONUCLEOTIDES SERVICES MARKET, BY TYPE, $M (2025–2030)

TABLE 14 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 15 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2025–2030)

TABLE 16 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY TYPE, $M (2019–2024)

TABLE 17 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY TYPE, $M (2025–2030)

TABLE 18 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTICS, BY TYPE, $M (2019–2024)

TABLE 19 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTICS, BY TYPE, $M (2025–2030)

TABLE 20 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2019–2024)

TABLE 21 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2025–2030)

TABLE 22 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, $M (2019–2024)

TABLE 23 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, $M (2025–2030)

TABLE 24 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY OFFERING, $M (2019–2024)

TABLE 25 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY OFFERING, $M (2025–2030)

TABLE 26 NORTH AMERICA SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2019–2024)

TABLE 27 NORTH AMERICA SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2025–2030)

TABLE 28 NORTH AMERICA SYNTHESIZED OLIGONUCLEOTIDES PRODUCTS MARKET, BY TYPE $M (2019–2024)

TABLE 29 NORTH AMERICA SYNTHESIZED OLIGONUCLEOTIDES PRODUCTS MARKET, BY TYPE, $M (2025–2030)

TABLE 30 NORTH AMERICA SYNTHESIZED OLIGONUCLEOTIDES SERVICES MARKET, BY TYPE, $M (2019–2024)

TABLE 31 NORTH AMERICA SYNTHESIZED OLIGONUCLEOTIDES SERVICES MARKET, BY TYPE, $M (2025–2030)

TABLE 32 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 33 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2025–2030)

TABLE 34 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY TYPE, $M (2019–2024)

TABLE 35 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY TYPE, $M (2025–2030)

TABLE 36 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTICS, BY TYPE, $M (2019–2024)

TABLE 37 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTICS, BY, $M (2025–2030)

TABLE 38 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2019–2024)

TABLE 39 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2025–2030)

TABLE 40 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, $M (2019–2024)

TABLE 41 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, $M (2025–2030)

TABLE 42 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY OFFERING, $M (2019–2024)

TABLE 43 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY OFFERING, $M (2025–2030)

TABLE 44 EUROPE SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2019–2024)

TABLE 45 EUROPE SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2025–2030)

TABLE 46 EUROPE SYNTHESIZED OLIGONUCLEOTIDES PRODUCTS MARKET, BY TYPE $M (2019–2024)

TABLE 47 EUROPE SYNTHESIZED OLIGONUCLEOTIDES PRODUCTS MARKET, BY TYPE, $M (2025–2030)

TABLE 48 EUROPE SYNTHESIZED OLIGONUCLEOTIDES SERVICES MARKET, BY TYPE, $M (2019–2024)

TABLE 49 EUROPE SYNTHESIZED OLIGONUCLEOTIDES SERVICES MARKET, BY TYPE, $M (2025–2030)

TABLE 50 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 51 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2025–2030)

TABLE 52 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY TYPE, $M (2019–2024)

TABLE 53 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY TYPE, $M (2025–2030)

TABLE 54 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTICS, BY TYPE, $M (2019–2024)

TABLE 55 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTICS, BYTYPE, $M (2025–2030)

TABLE 56 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2019–2024)

TABLE 57 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2025–2030)

TABLE 58 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, $M (2019–2024)

TABLE 59 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, $M (2025–2030)

TABLE 60 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY OFFERING, $M (2019–2024)

TABLE 61 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY OFFERING, $M (2025–2030)

TABLE 62 APAC SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2019–2024)

TABLE 63 APAC SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2025–2030)

TABLE 64 APAC SYNTHESIZED OLIGONUCLEOTIDES PRODUCTS MARKET, BY TYPE, $M (2019–2024)

TABLE 65 APAC SYNTHESIZED OLIGONUCLEOTIDES PRODUCTS MARKET, BY TYPE, $M (2025–2030)

TABLE 66 APAC SYNTHESIZED OLIGONUCLEOTIDES SERVICES MARKET, BY TYPE, $M (2019–2024)

TABLE 67 APAC SYNTHESIZED OLIGONUCLEOTIDES SERVICES MARKET, BY TYPE, $M (2025–2030)

TABLE 68 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 69 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2025–2030)

TABLE 70 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY TYPE, $M (2019–2024)

TABLE 71 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY TYPE, $M (2025–2030)

TABLE 72 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTICS, BY TYPE, $M (2019–2024)

TABLE 73 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTICS, BY TYPE, $M (2025–2030)

TABLE 74 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2019–2024)

TABLE 75 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2025–2030)

TABLE 76 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, $M (2019–2024)

TABLE 77 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, $M (2025–2030)

TABLE 78 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY OFFERING, $M (2019–2024)

TABLE 79 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY OFFERING, $M (2025–2030)

TABLE 80 LATAM SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2019–2024)

TABLE 81 LATAM SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2025–2030)

TABLE 82 LATAM SYNTHESIZED OLIGONUCLEOTIDES PRODUCTS MARKET, BY TYPE, $M (2019–2024)

TABLE 83 LATAM SYNTHESIZED OLIGONUCLEOTIDES PRODUCTS MARKET, BY TYPE, $M (2025–2030)

TABLE 84 LATAM SYNTHESIZED OLIGONUCLEOTIDES SERVICES MARKET, BY TYPE, $M (2019–2024)

TABLE 85 LATAM SYNTHESIZED OLIGONUCLEOTIDES SERVICES MARKET, BY TYPE, $M (2025–2030)

TABLE 86 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 87 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2025–2030)

TABLE 88 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY TYPE, $M (2019–2024)

TABLE 89 LATAM OLIGONUCLEOTIDE SYNTHESIS FOR RESEARCH MARKET, BY TYPE, $M (2025–2030)

TABLE 90 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTICS, BY TYPE, $M (2019–2024)

TABLE 91 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTICS, BY TYPE, $M (2025–2030)

TABLE 92 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2019–2024)

TABLE 93 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2025–2030)

TABLE 94 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, $M (2019–2024)

TABLE 95 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, $M (2025–2030)

TABLE 96 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY OFFERING, $M (2019–2024)

TABLE 97 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY OFFERING, $M (2025–2030)

TABLE 98 MEA SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2019–2024)

TABLE 99 MEA SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2025–2030)

TABLE 100 MEA SYNTHESIZED OLIGONUCLEOTIDES PRODUCTS MARKET, BY TYPE, $M (2019–2024)

TABLE 101 MEA SYNTHESIZED OLIGONUCLEOTIDES PRODUCTS MARKET, BY TYPE, $M (2025–2030)

TABLE 102 MEA SYNTHESIZED OLIGONUCLEOTIDES SERVICES MARKET, BY TYPE, $M (2019–2024)

TABLE 103 MEA SYNTHESIZED OLIGONUCLEOTIDES SERVICES MARKET, BY TYPE, $M (2025–2030)

TABLE 104 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2019–2024)

TABLE 105 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2025–2030)

TABLE 106 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY TYPE, $M (2019–2024)

TABLE 107 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY TYPE, $M (2025–2030)

TABLE 108 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTICS MARKET, BY TYPE, $M (2019–2024)

TABLE 109 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTICS, BY TYPE, $M (2025–2030)

TABLE 110 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2019–2024)

TABLE 111 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2025–2030)

TABLE 112 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, $M (2019–2024)

TABLE 113 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, $M (2025–2030)

TABLE 114 EUROFINS SCIENTIFIC SE – AT A GLANCE

TABLE 115 EUROFINS SCIENTIFIC SE – KEY FINANCIAL SUMMARY

TABLE 116 LGC LIMITED – AT A GLANCE

TABLE 117 LGC LIMITED – KEY FINANCIAL SUMMARY

TABLE 118 DANAHER CORPORATION – AT A GLANCE

TABLE 119 DANAHER CORPORATION – KEY FINANCIAL SUMMARY

TABLE 120 GENEDESIGN INC. – AT A GLANCE

TABLE 121 MARAVAI LIFESCIENCES INC. – AT A GLANCE

TABLE 122 KANEKA EUROGENTEC S.A. – AT A GLANCE

TABLE 123 GENERAL ELECTRIC COMPANY – AT A GLANCE

TABLE 124 GENERAL ELECTRIC COMPANY – KEY FINANCIAL SUMMARY

TABLE 125 THERMO FISHER SCIENTIFIC INC. – AT A GLANCE

TABLE 126 THERMO FISHER SCIENTIFIC INC. – KEY FINANCIAL SUMMARY

TABLE 127 MERCK KGAA – AT A GLANCE

TABLE 128 MERCK KGAA – KEY FINANCIAL SUMMARY

TABLE 129 GENSCRIPT BIOTECH CORPORATION – AT A GLANCE

TABLE 130 GENSCRIPT BIOTECH CORPORATION – KEY FINANCIAL SUMMARY

TABLE 131 NITTO DENKO AVECIA INC. – AT A GLANCE

 

List of Figures

 

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SUMMARY

FIG 9 PORTER’S FIVE FORCES ANALYSIS

FIG 10 SNAPSHOT OF GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET (2023)

FIG 11 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY OFFERING, $M (2019–2030)

FIG 12 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2019–2030)

FIG 13 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2019–2030)

FIG 14 WORLDWIDE MAJOR MARKETS FOR OLIGONUCLEOTIDE SYNTHESIS

FIG 15 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT

FIG 16 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY OFFERING, $M (2019–2030)

FIG 17 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2019–2030)

FIG 18 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2019–2030)

FIG 19 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, $M (2019–2030)

FIG 20 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT

FIG 21 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY OFFERING, $M (2019–2030)

FIG 22 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2019–2030)

FIG 23 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2019–2030)

FIG 24 EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, $M (2019–2030)

FIG 25 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT

FIG 26 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY OFFERING, $M (2019–2030)

FIG 27 APAC SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2019–2030)

FIG 28 APAC SYNTHESIZED OLIGONUCLEOTIDES PRODUCTS MARKET, BY TYPE, $M (2019–2030)

FIG 29 APAC SYNTHESIZED OLIGONUCLEOTIDES SERVICES MARKET, BY TYPE, $M (2019–2030)

FIG 30 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2019–2030)

FIG 31 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY TYPE, $M (2019–2030)

FIG 32 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTICS, BY TYPE, $M (2019–2030)

FIG 33 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2019–2030)

FIG 34 APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, $M (2019–2030)

FIG 35 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT

FIG 36 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY OFFERING, $M (2019–2030)

FIG 37 LATAM SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2019–2030)

FIG 38 LATAM SYNTHESIZED OLIGONUCLEOTIDES PRODUCTS MARKET, BY TYPE, $M (2019–2030)

FIG 39 LATAM SYNTHESIZED OLIGONUCLEOTIDES SERVICES MARKET, BY TYPE, $M (2019–2030)

FIG 40 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2019–2030)

FIG 41 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY TYPE, $M (2019–2030)

FIG 42 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTICS, BY TYPE, $M (2019–2030)

FIG 43 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2019–2030)

FIG 44 LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, $M (2019–2030)

FIG 45 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT

FIG 46 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY OFFERING, $M (2019–2030)

FIG 47 MEA SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2019–2030)

FIG 48 MEA SYNTHESIZED OLIGONUCLEOTIDES PRODUCTS MARKET, BY TYPE, $M (2019–2030)

FIG 49 MEA SYNTHESIZED OLIGONUCLEOTIDES SERVICES MARKET, BY TYPE, $M (2019–2030)

FIG 50 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2019–2030)

FIG 51 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY TYPE, $M (2019–2030)

FIG 52 MEA OLIGONUCLEOTIDE SYNTHESIS FOR THERAPEUTICS MARKET, BY APPLICATION, $M (2019–2030)

FIG 53 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2019–2030)

FIG 54 MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, $M (2019–2030)

FIG 55 PRODUCT BENCHMARKING OF KEY PLAYERS

FIG 56 EUROFINS SCIENTIFIC SE – REVENUE SPLIT BY GEOGRAPHY (2023)

FIG 57 DANAHER CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 58 GENERAL ELECTRIC COMPANY – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 59 THERMO FISHER SCIENTIFIC INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 60 MERCK KGAA – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 61 GENSCRIPT BIOTECH CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)